Real-World Outcomes in First-Line Venetoclax-Based Therapy in Patients With AML Ineligible for Intensive Chemotherapy: A Single Center Study

Clinical Lymphoma, Myeloma & Leukemia · Elsevier

Аннотация

Publication date: October 2026 Source: Clinical Lymphoma Myeloma and Leukemia, Volume 26, Issue 10 Author(s): Cheryl H. Chang, Allison O. Taylor, Nia M. Mitchell, Susan C. Locke, Jesse D. Troy, Rebecca P. Bystrom, Harry P. Erba, Sanghee Hong, Chenyu Lin, Thomas W. LeBlanc

Читать у издателя →

Похожие статьи